Sterling Capital Management’s Fennec Pharmaceuticals FENC Stock Holding History

Sterling Capital Management’s Portfolio FENC Stock Details FENC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$10.1K	Buy	952 +850	+833%	+$9.34K	﹤0.01%	2519
2026 Q2	$1.1K	Sell	102 -642	-86%	-$5.24K	﹤0.01%	3109
2026 Q1	$4.58K	Sell	744 -286	-28%	-$2.21K	﹤0.01%	2774
2025 Q4	$7.93K	Sell	1,030 -168	-14%	-$1.38K	﹤0.01%	2718
2025 Q3	$11.2K	Buy	1,198 +686	+134%	+$5.94K	﹤0.01%	2429
2025 Q2	$4.25K	Buy	512 +178	+53%	+$1.22K	﹤0.01%	2598
2025 Q1	$2.03K	Sell	334 -294	-47%	-$1.89K	﹤0.01%	2592
2024 Q4	$3.97K	Buy	628 +566	+913%	+$2.9K	﹤0.01%	2554
2024 Q3	$310	Buy	+62	New	+$359	﹤0.01%	3023

Other funds holding FENC

Essex Investment Management Boston, Massachusetts $675M AUM 61.81% 1-Year Est. Return

Sierra Summit Advisors Incline Village, Nevada $852M AUM 73.11% 1-Year Est. Return

Hartford Financial Management Hartford, Connecticut $448M AUM 24.02% 1-Year Est. Return

Master's Wealth Management Lancaster, Pennsylvania $343M AUM 11.33% 1-Year Est. Return

State of Alaska Department of Revenue Juneau, Alaska $9.6B AUM 34.67% 1-Year Est. Return

Pinnacle Wealth Planning Services Mansfield, Ohio $1.03B AUM 22.32% 1-Year Est. Return

GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return

PWMG

Private Wealth Management Group Princeton, New Jersey $445M AUM 13.54% 1-Year Est. Return

Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.86B AUM 20.09% 1-Year Est. Return

Sterling Capital Management's FENC Position: Q3 2026 in Review

Sterling Capital Management increased its Fennec Pharmaceuticals (FENC) stake by 833% in Q3 2026, buying an estimated $9.34K and bringing the position to 952 shares worth $10.1K. The position accounts for ﹤0.01% of the portfolio, ranked #2519.

Sterling Capital Management first reported a position in FENC in Q3 2024 and has held it in 9 quarters since. The position peaked at $11.2K in Q3 2025. 19 funds tracked by Wall St. Rank hold FENC as of Q3 2026.

Sterling Capital Management held 952 shares of Fennec Pharmaceuticals worth $10.1K as of Q3 2026.
Sterling Capital Management bought 850 Fennec Pharmaceuticals shares in Q3 2026, an estimated $9.34K.
Fennec Pharmaceuticals made up ﹤0.01% of Sterling Capital Management's portfolio in Q3 2026, its #2519 holding.
Sterling Capital Management first reported a position in Fennec Pharmaceuticals in Q3 2024 and has held it in 9 quarters since.
Sterling Capital Management's Fennec Pharmaceuticals position peaked at $11.2K in Q3 2025.
19 funds tracked by Wall St. Rank held Fennec Pharmaceuticals as of Q3 2026.

Based on Sterling Capital Management's 13F filing for Q3 2026, filed 22 Oct 2026.